Mycophenolate mofetil and Cutaneous vasculitis - a phase IV clinical study of FDA data

Summary:

Cutaneous vasculitis is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are male, 60+ old, have been taking the drug for 6 - 12 months also take Prednisone, and have Henoch-schonlein purpura.

The phase IV clinical study analyzes which people have Cutaneous vasculitis when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Cutaneous vasculitis?

Cutaneous vasculitis (an inflammatory process affecting the vessel wall that leads to its damage) is found to be associated with 245 drugs and 344 conditions by eHealthMe. Check the latest studies of Cutaneous vasculitis.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 26, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 39 people (0.04%) have Cutaneous vasculitis.

Could Mycophenolate mofetil cause Cutaneous vasculitis?

Among these 39 people:

How long have people been on Mycophenolate mofetil when they have Cutaneous vasculitis? *

What is the gender of people who have Cutaneous vasculitis when taking Mycophenolate mofetil? *

female: 20.59 %
male: 79.41 %

What is the age of people who have Cutaneous vasculitis when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

What are other side effects people have besides Cutaneous vasculitis? *

Arthritis (form of joint disorder that involves inflammation of one or more joints): 15 people, 38.46%
Drug Ineffective: 12 people, 30.77%
Henoch-Schonlein Purpura (inflammation of the blood vessels in the skin and other body organs): 11 people, 28.21%
Abdominal Pain: 8 people, 20.51%
Chronic Kidney Disease: 8 people, 20.51%
Cystitis Escherichia (inflammation of the wall of the bladder by bacteria escherichia coli): 8 people, 20.51%
Rectal Haemorrhage (bleeding from anus): 8 people, 20.51%
Haematochezia (passage of stools containing blood): 8 people, 20.51%
Pyelonephritis Acute (sudden inflammation of kidney caused by bacteria): 8 people, 20.51%
Purpura (purplish discoloration of the skin): 8 people, 20.51%

What are the existing conditions these people have? *

Inflammatory Bowel Disease: 8 people, 20.51%
Henoch-Schonlein Purpura (inflammation of the blood vessels in the skin and other body organs): 8 people, 20.51%
Immunodeficiency Disorders: 7 people, 17.95%
Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 6 people, 15.38%
Glomerulonephritis Membranous (nephritis with inflammation of the capillary loops in the renal glomeruli): 6 people, 15.38%
Ulcerative Colitis (inflammatory bowel disease (ibd). it causes swelling, ulcerations, and loss of function of the large intestine): 1 person, 2.56%
Transplant Rejection (a transplant material is not worked): 1 person, 2.56%
Psoriasis (immune-mediated disease that affects the skin): 1 person, 2.56%
Iga Nephropathy (kidney disease- condition prevents the kidneys from filtering waste): 1 person, 2.56%
Disseminated Tuberculosis: 1 person, 2.56%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Cutaneous vasculitis?

- Check whether Cutaneous vasculitis is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,461 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Cutaneous vasculitis:

Cutaneous vasculitis (245 drugs)

Browse all the conditions that are associated with Cutaneous vasculitis:

Cutaneous vasculitis (344 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.